BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2025 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
BDSX on Nasdaq
Shares outstanding
9,724,771
Price per share
$11.08
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
1,342,428
Total reported value
$9,128,098
% of total 13F portfolios
0%
Share change
+193,248
Value change
+$1,239,023
Number of holders
25
Price from insider filings
$11.08
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SCHULER JACK W 24% -11% $15,872,226 +$1,240,871 2,333,945 +8.5% SCHULER JACK W 23 Jan 2026
Soleus Capital Master Fund, L.P. 6.3% $4,000,000 500,000 Soleus Capital Master Fund, L.P. 12 Jan 2026
Telemark Asset Management, LLC 5.4% +32% $2,909,460 +$680,060 427,824 +31% Telemark Asset Management, LLC 22 Jan 2026

As of 31 Dec 2025, 25 institutional investors reported holding 1,342,428 shares of BIODESIX INC - Common Stock, par value $0.001 per share (BDSX). This represents 14% of the company’s total 9,724,771 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) together control 14% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Telemark Asset Management, LLC 3.4% 327,824 -21% 0.22% $2,229,203
Aberdeen Group plc 2.7% 262,425 0% $1,784,490
VANGUARD GROUP INC 2% 192,138 +5.6% 0% $1,306,538
Monashee Investment Management LLC 1.2% 112,344 +12% 0.43% $763,939
PERCEPTIVE ADVISORS LLC 1.1% 108,694 0% 0.01% $739,119
GSA CAPITAL PARTNERS LLP 0.66% 64,483 +33% 0.04% $438,000
PERKINS CAPITAL MANAGEMENT INC 0.46% 44,783 -15% 0.24% $304,524
GEODE CAPITAL MANAGEMENT, LLC 0.44% 42,453 +5.6% 0% $288,753
Balyasny Asset Management L.P. 0.34% 33,017 -23% 0% $224,516
Trexquant Investment LP 0.28% 27,542 0% $187,286
CITADEL ADVISORS LLC 0.27% 25,985 0% $176,698
BlackRock, Inc. 0.25% 24,466 0% 0% $166,369
STATE STREET CORP 0.18% 17,802 +16% 0% $121,054
Shay Capital LLC 0.17% 16,145 +15% 0.02% $109,786
DRW Securities, LLC 0.16% 15,372 0.01% $104,529
NORTHERN TRUST CORP 0.11% 11,134 0% $75,711
Cetera Investment Advisers 0.1% 10,000 0% $68,000
Allworth Financial LP 0.05% 4,965 0% 0% $33,762
Tower Research Capital LLC (TRC) 0% 193 -70% 0% $1,312
Quattro Advisors LLC 0% 187 0% 0% $1,272
Fortitude Family Office, LLC 0% 171 0% 0% $1,163
BANK OF AMERICA CORP /DE/ 0% 143 +377% 0% $972
GROUP ONE TRADING LLC 0% 100 0% 0% $680
MORGAN STANLEY 0% 61 -20% 0% $415
FMR LLC 0% 1 0% 0% $7

Institutional Holders of BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,342,428 $9,128,098 +$1,239,023 $6.80 25
2025 Q3 1,148,993 $8,674,797 +$8,674,797 $7.55 25